| Prostate Cancer |
1 |
1 |
| Breast Cancer |
0 |
0.69 |
| Tumor |
0 |
0.68 |
| Ovarian Cancer |
0 |
0.6 |
| Genomic Medicine |
0 |
0.58 |
| Cancer |
0 |
0.47 |
| Metastasis |
0 |
0.99 |
| Prostate |
0 |
0.98 |
| Chemotherapy |
0 |
0.21 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.2 |
| HIV Infection |
0 |
0.2 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.16 |
| Poly ADP-Ribose Polymerase (PARP) Inhibitor |
0 |
0.15 |
| Biopsy |
0 |
0.1 |
| Clinical Research |
0 |
0.1 |
| Genetics |
0 |
0.1 |
| Receptors |
0 |
0.1 |
| Medical Life |
0 |
0.07 |
| Bone |
0 |
0.05 |
| California |
0 |
0.05 |
| Clinician Health and Well-Being |
0 |
0.05 |
| Prognosis |
0 |
0.05 |